Speeches and presentations

Tony Wood, Chief Scientific Officer, attended the Citi European Healthcare Conference in London on Tuesday, 17 June 2025.

Kimberly Smith, Head of R&D at ViiV Healthcare, attended the Goldman Sachs Global Healthcare Conference in Miami on Monday, 9 June 2025.

David Redfern, President Corporate Development, attended the NYSE Health Care Virtual Investor Access Day on Thursday, 5 June 2025.

Julie Brown, Chief Financial Officer, attended the BNP Paribas Exane CEO Conference in Paris on Thursday, 5 June 2025.

David Redfern, President, Corporate Development, attended the Goldman Sachs Biopharma Innovation Summit in London on Thursday, 27 March 2025.

Julie Brown, Chief Financial Officer, participated in a virtual fireside chat at the BNP Paribas Exane Healthcare Conference on Tuesday, 25 March 2025.

Luke Miels, Chief Commercial Officer, participated in a fireside chat at the TD Cowen 45th Annual Health Care Conference in Boston on Monday, 3 March 2025.

Emma Walmsley, Chief Executive Officer, presented at the 43rd annual JP Morgan Healthcare Conference on Tuesday 14 January. The 40 minute session included a presentation and a moderated Q&A discussion.

On 17 December, GSK management held a virtual event, "Early pipeline", featuring a presentation and an interactive Q&A session.

GSK held a virtual event "Getting Ahead of Multiple Myeloma: Update from ASH" on 10 December, providing a recap on data presented at the 66th ASH (American Society of Hematology) Annual Meeting.

Hesham Abdullah, SVP Global Head Oncology, attended Citi's 2024 Global Healthcare Conference in Miami on Thursday, 5 December 2024.

Emma Walmsley, Chief Executive Officer, participated in a virtual fireside chat at the 2024 Redburn Atlantic CEO Conference on Wednesday, 4 December 2024.

Phil Dormitzer, SVP, Head of Vaccines R&D, attended the 7th Annual Evercore ISI HealthCONx Conference in Miami on Wednesday, 4 December 2024.

David Redfern, President Corporate Development, attended the Bernstein Premium Review Conference in Paris on Wednesday, 27 November 2024.

Tony Wood, Chief Scientific Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, 19 November 2024 in London.

Julie Brown, Chief Financial Officer, participated in a fireside chat at the JP Morgan UK Leaders Conference on Tuesday, 19 November 2024 in London.

Emma Walmsley, Chief Executive Officer, participated in a fireside chat at Guggenheim's Inaugural Healthcare Innovation Conference on Tuesday, 12 November 2024 in Boston.

David Redfern, President, Corporate Development, attended the Bernstein 21st Pan European Annual Strategic Decisions Conference in London on Wednesday, 25 September 2024.

Julie Brown, Chief Financial Officer, participated in a fireside chat at the BofA Global Healthcare Conference on Thursday, 19 September 2024 in London at 09:05 BST.

David Redfern, President, Corporate Development, participated in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference taking place in New York on Thursday, 5 September 2024 at 4:05am EST.

GSK management held a virtual event on 17 June at 8:00 AM EDT / 1:00 PM BST. The event, "Getting Ahead of Oncology," featured a presentation and an interactive Q&A session. A replay is available on demand.

Julie Brown, Chief Financial Officer, participated in a fireside chat at the BNP Paribas Exane CEO Conference in Paris on Thursday, 6 June 2024.

David Redfern, President, Corporate Development, attended the J.P. Morgan EMEA All Stars Forum in Boston on Wednesday, 22 May 2024.

David Redfern, President, Corporate Development, attended the Berenberg European Conference in New York on Tuesday, 21 May 2024.

David Redfern, President, Corporate Development, attended the Barclays European Select Conference in New York on Monday, 20 May 2024.

Julie Brown, Chief Financial Officer, participated in a fireside chat at the BNP Paribas Exane Healthcare Conference which took place on Tuesday, 26 March 2024.

GSK’s VP of Reputation and Responsible Business, Clare Griffin, and VP of Sustainability, Claire Lund, presented a 45 minute virtual event focused on the newest set of ESG data for the company – the 2023 ESG Performance Report.

Julie Brown, Chief Financial Officer, attended the Berenberg UK Corporate Conference on Tuesday, 19 March 2024.

Luke Miels, Chief Commercial Officer, participated in a fireside chat at TD Cowen's Healthcare Conference taking place on Monday 4 March at 2:50pm ET / 7:50pm GMT.

Julie Brown, Chief Financial Officer, attended the London UBS European Healthcare Conference on Tuesday, 28 February 2024.

Emma Walmsley, Chief Executive Officer, participated in the 42nd annual JP Morgan Healthcare Conference on Tuesday 9 January at 07:30-08:10am PST / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion.

GSK management held a virtual event on 30 November at 8:00 AM EST / 1:00 PM GMT. The event featured a presentation and an interactive Q&A session. A replay is available on demand.

Phil Dormitzer, SVP and Global Head Vaccines R&D and Infectious Disease Research, discussed the progress being made in vaccine innovation during a fireside chat at the Evercore ISI HealthCONx Conference on Wednesday, 29 November 2023, 12:30pm UK / 7:30am ET.

Luke Miels, Chief Commercial Officer, discussed the progress being made at GSK during a fireside chat at the Redburn Atlantic CEO Conference on Wednesday, 29 November 2023 at 9:00am UK.

Tony Wood, Chief Scientific Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Thursday, 16 November at 9:00am GMT.

ViiV Healthcare management held a virtual event on 28 September at 9:00 AM EDT / 2:00 PM BST. The event, "Getting ahead of HIV," featured a presentation and an interactive Q&A. A recording of the session is available on YouTube.

Emma Walmsley, Chief Executive Officer, participated in a fireside chat at the BofA Global Healthcare Conference on Thursday 14 September at 09:05 BST.

Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 18th Annual BioPharma Conference which took place Thursday, September 7th at 8:50am ET/1:50pm UK.

The virtual event featured a presentation, four breakout sessions and an interactive Q&A. Recordings of all sessions are available on YouTube.

Tony Wood, Chief Scientific Officer, discussed progress made in R&D during a fireside chat on Tuesday, 13 June at 9:20am PT/12:20pm ET/5:20pm UK during Goldman Sachs’ 44th Annual Global Healthcare Conference, in Dana Point, California.

During the 45 minute session Alberto Fernandez, SVP of Global Clinical Operations at GSK and Dr. Kimberly Smith, SVP and Head of R&D at ViiV Healthcare, provided insights on the importance of clinical trial diversity including support from a 17-year retrospective study. During the session, the leaders also provided an overview of GSK’s work to ensure clinical trials reflect the populations most impacted by a disease and explored a HIV case study that demonstrated the power of clinical trial diversity in action. The presentation was followed by an opportunity for audience Q&A.

Emma Walmsley, Chief Executive Officer, presented at the 41st annual JP Morgan Healthcare Conference on Tuesday 10 January at 07:30-08:10am PT / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion. 

Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, discussed the progress being made in HIV innovation during a fireside chat at the Evercore ISI HealthCONx Conference Wednesday, November 30^th, 1pm UK / 8:00am ET.

David Redfern, Chief Strategy Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, 16 November 2022 at 09:45 GMT.

GSK’s response to an Investor Forum letter, regarding GSK’s redefined operating model post-Demerger.

After presenting the positive AReSVi-006 pivotal phase III results for our RSV (respiratory syncytial virus) older adults vaccine candidate at IDWeek 2022, GSK management hosted an investor science event on 21 October 2022.

Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 16 September at 0815 BST.

Roger Connor, President Global Vaccines & Global Health and Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 17th Annual BioPharma Conference which took place Wednesday, September 7 at 1:50pm ET/6:50pm UK. 

Tobias Hestler, CFO GSK Consumer Healthcare participated in a fireside chat at the dB Access Global Consumer Conference on 14th June 2022 at 14:45pm BST (15:45pm CEST, 9:45am EDT).

Deborah Waterhouse, CEO, ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in the HIV space during a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference, Monday, June 13^th at 10:00pm UK / 5:00pm ET

Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in HIV innovation during a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 24^th at 2:15pm UK / 9:15am ET.​

Brian McNamara, CEO Designate of Consumer Healthcare, participated in a fireside chat with JPMorgan analyst Celine Pannuti as part of her series of discussions with consumer staples CEOs. In the conversation Brian discussed the growth outlook across various consumer health categories, recent innovation trends and progress towards becoming a standalone company. 

Claire Lund, Vice President Environmental Sustainability, hosted our first ESG Investor Education Event focusing on our environment strategy, 5 April 2022 at 15:00 BST / 10:00 EDT.

Tobias Hestler, CFO Designate of Consumer Healthcare, participated in a fireside chat at the UBS Global Consumer and Retail Conference hosted by UBS analyst Guillaume Delmas.

Hal Barron, Chief Scientific Officer and President R&D, discussed the progress GSK is making in R&D during a fireside chat at the Cowen 42nd Annual Health Care Conference taking place virtually on Monday, 7 March 2022 at 4:10pm UK/11:10pm ET.

GSK's Consumer Healthcare Capital Markets Day took place on Monday 28 February 2022. This event provided details on our strategy, brands, capabilities and operations, as well as detailed financial information and future growth ambitions ahead of the proposed listing on the London Stock Exchange following the anticipated demerger from GSK mid-2022.

Roger Connor, President Global Vaccines & Global Health, particpated in a panel hosted by FCLT Global on Thursday, February 10^th at 8:00am ET/1:00pm GMT.  The panel focused on navigating the complexity of long-term strategies and investment since financing healthcare advancements, and particularly vaccine development, became central priority with the onset of COVID19.

Emma Walmsley, Chief Executive Officer, presented at the 40th annual JP Morgan Healthcare Conference on Tuesday 11 January at 07:30-08:10am ET / 12:30-13:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion. 

Emma Walmsley, Chief Executive Officer, participated in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top, on Thursday, 6 January 2022 at 8:00am ET.

Harmony Garges, SVP and Chief Medical Officer ViiV Healthcare, presented at the virtual Morgan Stanley ESG Insights Conference and provided an overview of ViiV’s mission to leave no person living with HIV behind and how it aligns with ViiV’s ESG efforts.

Brian McNamara, CEO of GSK Consumer Healthcare, participated in a virtual fireside chat at the 2021 Redburn CEO Conference. He provided an overview of our business and broader industry.

GSK hosted a ‘Meet GSK management’ event on 29 November 2021 at 15:00 GMT / 10:00 EST.

Tobias Hestler, CFO GSK Consumer Healthcare, participated in a virtual fireside chat at the UBS European Conference hosted by analyst Guillaume Delmas.

GSK held an investor science event for daprodustat’s ASCEND Phase III programme at 12 noon EST/ 5pm GMT on 7 November 2021.

Sir Jonathan Symonds, Chairman, and Manvinder Singh Banga, Senior Independent Non-Executive Director, participated in an Investor Forum meeting on Thursday 7 October 2021.

Rino Rappuoli, Senior Vice President Global Head of Vaccines R&D, participated in a fireside chat at Guggenheim’s 2^nd Annual Vaccine and Infectious Disease Day which took place on Wednesday 6 October 2021 at 1:00pm ET. 

Tobias Hestler, CFO for GSK Consumer Healthcare participated in a virtual fireside chat at the Bernstein Annual Pan European Strategic Decisions Conference.

Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 17 September at 0815 BST.

Brian McNamara, CEO GSK Consumer Healthcare, joined a virtual fireside chat hosted by Barclay’s analyst, Iain Simpson.  He provided an overview of the Consumer Healthcare business and our category leading brands. 

Dr. Kimberly Smith, Head of R&D, ViiV Healthcare participated in a fireside chat at Citi’s 16th Annual Biopharma Conference taking place on Thursday 9 September 2021 at 18:25 UK / 1:25pm EDT. Dr. Smith provided an update on ViiV Healthcare’s progress in advancing HIV science and R&D.

Hal Barron, Chief Scientific Officer and President R&D, joined a virtual fireside chat hosted by Guggenheim analyst Seamus Fernandez at Guggenheim’s Biopharma Strategy Series.

The event, 'Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation' took place Tuesday, 29 June 2021 at 19:00 BST / 14:00 EDT, during which he provided an update on the progress GSK is making in R&D.

Emma Walmsley, CEO, and other members of CET hosted a virtual investor update at 14:00-17:30 BST on Wednesday 23 June. The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.

Brian McNamara, CEO, GSK Consumer Healthcare, presented at the conference and provided an introduction to GSK Consumer Healthcare and outlined our purpose, strategy, category-leading brands and capabilities, as well as an overview of the consumer healthcare sector.

Emma Walmsley, CEO, presented at CECP’s Biopharma Investor Forum on Tuesday 8 June at 8:40 EST/13:40 BST, during which she provided an overview on our approach to ESG. The presentation was followed by a moderated Q&A session.

Deborah Waterhouse, CEO of ViiV Healthcare, participated in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 10 at 8:35am ET/1:35pm GMT, during which she provided an update on the progress GSK is making in the HIV space.

Hal Barron, Chief Scientific Officer and President R&D, participated in a fireside chat at the Cowen 41st Annual Health Care Conference on Monday, March 1 2021 at 5:20pm GMT /12:20pm ET, during which he discussed updates on the progress GSK is making in R&D.

Axel Hoos, GSK Senior Vice-President Oncology R&D, joined a Fireside Chat with Seamus Fernandez at the Guggenheim Healthcare Talks 2021 Oncology Days, Thursday, February 11, at 10AM ET, where the duo discussed GSK Oncology R&D progress.

Hal Barron, Chief Scientific Officer and President R&D, presented at the 39th annual JP Morgan Virtual Healthcare Conference on Tuesday 12 January at 10:50-11:30am ET / 15:50-16:30 GMT.  The presentation was followed by a Q&A session. 

Emma Walmsley, CEO, hosted a fireside chat at the Goldman Sachs 13th annual healthcare unscripted CEOs conference on Tuesday 5 January at 12:00 GMT

Phil Thomson, President Global Affairs, hosted a fireside chat at the Morgan Stanley ESG Insights Conference on Wednesday, 9 December 2020 at 15:25 GMT / 10:25am EST.

Luke Miels, President Global Pharmaceuticals, hosted a fireside chat at Evercore ISI HealthCONx Conference on Tuesday, 1 December 2020 at 13:00 GMT / 8:00am EST, during which provided an update on the progress GSK is making in the global pharmaceuticals and vaccines business.

GSK held an investor and analyst call hosted by Hal Barron, Chief Scientific Officer and President R&D, Roger Connor, President, GSK Vaccines, and Emmanuel Hanon, SVP and Head of Vaccines R&D, and discussed data on two respiratory syncytial virus (RSV) vaccine candidates to be presented at ID Week.

This event took place on Thursday 22 October at 3:30pm CET / 2:30pm BST / 9:30am EDT.

Emma Walmsley, CEO, hosted a fireside chat at the BofA Global Healthcare Conference on Thursday 17 September at 0815 BST.

Hal Barron, Chief Scientific Officer and President R&D, hosted a fireside chat at the Citi 15th Annual Biopharma Conference took place Wednesday 9 September 2020 at 16:40 BST/11:40am EDT, during which he provided an update on the progress GSK is making in the R&D pipeline.

GSK held an investor/analyst call hosted by David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO, ViiV Healthcare and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare to discuss the final efficacy analysis from the global HIV Prevention Treatment Network (HPTN) 083 study evaluating investigational long-acting cabotegravir for HIV prevention.

This event took place on: Thursday 9 July at 14:00 BST / 09:00 EDT

Axel Hoos, Senior Vice-President Oncology R&D, hosted a Fireside Chat at the Guggenheim Healthcare Talks Idea Forum, Oncology Day, held in New York City on Thursday, February 13th, during which he provided an update on GSK Oncology R&D progress.

Emma Walmsley, CEO, presented at the 38th annual JP Morgan Healthcare Conference in San Francisco on Tuesday 14 January, and provided an overview of GSK’s priorities and the progress the company made during 2019.  The presentation was followed by a Q&A session. 

On Tuesday, 17 December 2019 at 17:00 GMT / 12:00 EST, Hal Barron, Chief Scientific Officer and President of R&D, Luke Miels, President Pharmaceuticals and Axel Hoos, SVP Oncology R&D hosted an investor/analyst conference call to discuss GSK’s pivotal DREAMM-2 data on belantamab mafodotin (GSK’916).

On Monday, 30 September 2019, Dr Hal Barron, Chief Scientific Officer and President R&D and Luke Miels, President, GSK Global Pharmaceuticals hosted an investor conference call following the presentation of the PRIMA data on Zejula (niraparib) and the INDUCE-1 data on GSK’609 (ICOS) at the 2019 European Society for Medical Oncology (ESMO) congress. The call also featured participation from an external expert in ovarian cancer and other GSK senior oncology leaders.

Roger Connor, President, GSK Vaccines, hosted an educational session on GSK’s Vaccines business at our manufacturing site in Wavre, Belgium on Thursday 26 September at 13:30 CET / 12:30 BST / 7:30 EDT.

Hal Barron, Chief Scientific Officer and President R&D, hosted a fireside chat at Goldman Sachs’ 40^th Annual Global Healthcare Conference, which took place in Rancho Palos Verdes, California on Wednesday 12 June, during which he has provided an update on the progress being made in GSK’s R&D organisation.

David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, and Deborah Waterhouse, CEO of ViiV Healthcare, hosted a fireside chat at the Jefferies 2019 Healthcare Conference in New York on Thursday 6 June, during which they provided an update on the progress GSK and ViiV Healthcare have made this year.

Tobias Hestler, CFO GSK Consumer Healthcare, hosted a fireside chat at the Bernstein Consumer Healthcare & Nutrition Seminar in London on Tuesday 4 June during which he provided an update on the Consumer Healthcare business and the formation of a new, world-leading Consumer Healthcare joint venture.

David Redfern, Chairman ViiV Healthcare, Deborah Waterhouse, CEO ViiV Healthcare and Dr Kimberly Smith, VP Global Research & Medical Strategy hosted a ViiV Healthcare analyst call on Tuesday 30 April to discuss ViiV Healthcare’s recent regulatory activities and provide an update on the pipeline.

Luke Miels, President Global Pharmaceuticals, hosted a fireside chat at the Cowen & Co. 39th Annual Health Care Conference 2019 in Boston on Tuesday 12 March, during which he provided an update on the progress GSK is making in the global pharmaceuticals and vaccines business.

Brian McNamara, CEO GSK Consumer Healthcare, hosted a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference that took place in New York City on Thursday 28 February during which he provided an update on the Consumer Healthcare business and the formation of a new, world-leading Consumer Healthcare joint venture.

Axel Hoos, SVP Oncology R&D, hosted a Fireside Chat at the Guggenheim Healthcare Talks Idea Forum - Oncology Day held in New York City on Thursday 14 February during which he provided an update on GSK Oncology R&D progress.

Emma Walmsley, CEO, gave a presentation at the 37th annual JP Morgan Healthcare Conference in San Francisco on Tuesday 8 January, providing an overview of GSK’s priorities and the progress the company made during 2018.